SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending as the community debates whether the stock is a deep-value turnaround play or a failing brand, with discussions centering on massive insider buying from top leadership, planned layoffs, and potential tariff refunds. While many retail investors are cautious due to persistent selling pressure and negative sentiment regarding recent product strategy, others are accumulating at current lows, betting that the company will recover through restructuring and high-profile upcoming sports events.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently driving intense debate as investors weigh record-breaking revenue growth against persistent concerns over its high valuation. While many in the community are celebrating the strong earnings beat and accelerating AI demand, others are skeptical, with active discussions focusing on potential market manipulation and the sustainability of the stock's premium multiple.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is experiencing high volatility as investors react to legislative updates regarding the Clarity Act and its potential impact on stablecoin yields. The community remains deeply divided, with some traders focused on bullish technical breakouts and long-term infrastructure utility, while others are wary of regulatory hurdles, ongoing class-action litigation, and recent analyst downgrades.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is trending ahead of its upcoming earnings report as investors debate whether the company's massive hiring and capacity expansion signal a major upside or if governance concerns and margin pressures will persist. The community remains deeply divided, with bulls pointing to the company's critical role in AI infrastructure and its current valuation discount, while bears highlight persistent leadership skepticism and historical price volatility.

SKK Holdings Ltd. operates as a holding company, which engages in the provision of civil engineering services in subsurface utility works, including power and telecommunication cable laying, water pipeline and sewer rehabilitation works. The company was founded by Chun Seong Ng and Koon Kiat Sze on October 16, 2013 and is headquartered in Singapore.

SKK Holdings Ltd. - Ordinary Shares - Class A

SKK Holdings Ltd

SKK Holdings is experiencing extreme volatility following a significant drone asset acquisition agreement, sparking intense community debate between traders chasing the low-float momentum and skeptics warning of dilution risks. Investors are closely monitoring the stock's rapid price swings and frequent halts as participants argue over the company's valuation versus its potential as a short-term squeeze candidate.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending following the announcement of its $643 million acquisition of Eigen AI, a strategic move aimed at optimizing inference performance for its Token Factory platform. While investors are debating the company's valuation and long-term capital strategy, the community remains heavily focused on its infrastructure build-out and aggressive growth guidance ahead of upcoming earnings.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as investors react to a new commercialization partnership and recent analyst coverage that highlights significant potential in the firm's localized prostate cancer program. The community is actively debating the stock's valuation, upcoming data readouts, and the strategic positioning of management as the company works toward a BLA filing.

Duolingo, Inc. is a language-learning website and mobile application, which engages in the development of a free language learning website and crowd sourced text translation platform. It offers Duolingo for Schools, a free, web-based tool that aims to make it easier for teachers to use the Duolingo platform in a structured learning environment, and English Test, an online, on-demand assessment of English proficiency. The company was founded by Luis von Ahn and Severin Hacker in 2011 and is headquartered in Pittsburgh, PA.

Duolingo Inc - Ordinary Shares - Class A

Duolingo Inc

Duolingo is seeing intense investor debate as the market reacts to cooling bookings growth and a strategic pivot prioritizing user engagement over short-term monetization. While community sentiment is heavily polarized between skeptics citing AI disruption and long-term bulls highlighting the company's strong free cash flow and dominant market position, the stock remains a focal point for those looking for a potential turnaround play.

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

Cns Pharmaceuticals Inc

Cns Pharmaceuticals is seeing significant market activity driven by an oversubscribed private placement financing, which investors are weighing against concerns over historical share dilution. The community is actively debating whether the move signals a genuine valuation shift or a typical volatile setup, with traders closely monitoring key support levels for signs of a parabolic continuation.

GeneDx Holdings Corp. operates as a health intelligence company. It engages in healthcare with the use of its collected disease data sets. It offers exome and genome testing for diagnosis of genetic disease. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

GeneDx Holdings Corp - Ordinary Shares - Class A

GeneDx Holdings Corp

GeneDx Holdings is seeing significant volatility as investors digest a guidance reset and conflicting institutional signals, with the community actively debating whether the recent sell-off represents a buying opportunity or a deeper trend of fundamental weakness. The stock remains a major talking point as market participants analyze heavy insider buying against concerns about the company's long-term growth sustainability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review

Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive...

Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities

Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities PR Newswire SAN DIEGO, March 12, 2026 SAN...

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026 PR Newswire SAN DIEGO, Feb. 23...

Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update

Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update PR Newswire SAN DIEGO, Feb. 12, 2026...

Illustration showing chimeric antigen receptor (CAR) T cells (blue and green) being used to treat non-small cell lung cancer (NSCLC). | Representative image: Getty Images

Why Did Aethlon Medical Stock Tumble Over 12% Today?

Aethlon Medical's stock drew investor attention after the company announced a private placement and warrant inducement deal. 

Equity

Aethlon Medical's stock drew investor attention after the company announced a private placement and warrant inducement deal. 


Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million

Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million Aethlon Medical Announces Pricing of a Private...

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier Binds to Extracellular Vesicles in Long COVID patient samples and Decreases...

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update PR Newswire SAN DIEGO, Nov. 12, 2025...

What to Expect from Aethlon Medical's Earnings

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025 Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference...

Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. It develops Aethlon Hemopurifier, which is a clinical-stage immunotherapeutic device designed to combat cancer and life-threatening viral infections. The firm operates through the following segments: Aethlon and ESI. The Aethlon segment is involved in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce on April 17, 1991 and is headquartered in San Diego, CA.

AEMD
Aethlon Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest AEMD News

AEMDAethlon Medical Inc